Vitala provides high sensitivity drug testing of mitochondrial activity for Biotechs and Pharma companies in early pre-clinical phases using in vitro and in vivo models. Leveraging our patented technology and the power of AI, Vitala delivers deep insights into metabolic kinetics at the mitochondrial level, being able to provide unprecedented answers on toxicity, effectiveness, and confirmation of mechanism of action. This will save the pharmaceutical industry billions of dollars in drug testing and save animal lives. Located in Barcelona, as a spinoff of The Institute of Bioengineering of Catalonia, we have started international commercialization.